期刊文献+

2003-2006年湖北地区三级医院儿童感染大肠埃希菌耐药性分析 被引量:8

Antibiotic Resistance Changing of Esherichia coli in Third Grade Hospitals of Hubei Province:A Dynamic Investigation
在线阅读 下载PDF
导出
摘要 目的动态调查分析湖北地区儿童感染大肠埃希菌的耐药性变迁趋势,为临床合理使用抗菌药物提供科学依据。方法对湖北地区17所三级医院2003-2006年儿童患者各类临床标本,采用WHONET4-5软件对2901株大肠埃希菌的耐药率进行统计分析。结果4年中湖北地区儿童感染大肠埃希菌除对碳青酶烯类抗菌药物亚胺培南和美罗培南保持100%的敏感率外,对其他常用抗菌药物的耐药率多呈上升趋势,但儿童组大肠埃希菌耐药率低于成人组;对氨苄西林耐药率最高,达84%~90%;耐药率较低的抗菌药物有阿米卡星、头孢西丁、头孢他啶、头孢吡肟,为3%~25%。结论湖北地区儿童感染大肠埃希菌的耐药性呈上升趋势,应切实采取有效措施,合理使用抗菌药物,控制耐药菌的传播与流行。 OBJECTIVE To investigate dynamically antibiotic resistance changing of Escherichia coli in Hubei province and provide the reference for clinical rational application of antibiotics. METHODS The WHONET4-5 software was used to analyze the antibiotic resistant rates of 2901 strains of E. coli isolated from all kinds of clinical specimen of children from 2003 to 2006 in the third grade hospitals of Hubei province. RESULTS Drugresistance rate of E. coli in children group was lower than that in adult group. Except for 100.0% susceptibility to carbopenems such as imipenem and Meropenem, in the four years, drug-resistance of the other antibiotics showed ascending tendency. Ampicillin showed the highest drug-resistance rate (84%- 90%). The lower (3%- 25%) were amikaein, eefoxitin, eeftazidime, eefepime. CONCLUSIONS Antibiotic resistance of E. coli in children in Hubei province showed the ascending tendency. We should take effective rneasurement to control the spread and prevalence of the drug-resistant bacteria.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第10期1471-1472,1484,共3页 Chinese Journal of Nosocomiology
关键词 湖北地区 三级医院 儿童 大肠埃希菌 耐药性 Hubei Province The third grade hospital Children Escherichia coli Drug-resistance
  • 相关文献

参考文献4

二级参考文献21

  • 1方向群,刘又宁.藻酸盐在铜绿假单胞菌肺部感染中的致病作用及与细胞因子的关系[J].中华医院感染学杂志,2004,14(2):126-129. 被引量:27
  • 2柴栋,王睿,裴斐,方翼.藻酸盐抗体的制备及其对铜绿假单胞菌生物被膜的影响[J].中华医院感染学杂志,2004,14(3):245-247. 被引量:23
  • 3Anderl JN,Franklin MJ,Stewart PS.Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin[J].Antimicrob Agents Chemother,2000,44(7):1818-1824.
  • 4Quale JM,Landman D,Bradford PA,et al.Molecular epidemiology of an citywide outbreak of an extended spectrum-beta-lactamase-producing Klebsiella pneumoniae infection[J].Clin Infect Dis,2002,35(7):834-841.
  • 5National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. Ninth informational supplement M100-S9. NCCLS, 1999.19(1):72-75.
  • 6Schroeder CM, Meng JH, Zhao SH,et al.Antimicrobial resistance of Escherichia coli O26,O103,O111,O128, and O145 from animals and humans[J]. Emerg Infect Dis,2002,8(12):1409-1414.
  • 7Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 8Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 9Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 10Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.

共引文献1003

同被引文献51

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部